-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GS-0201 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GS-0201 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GS-0201 in Solid Tumor Drug Details: Small molecule is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GS-0201 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GS-0201 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GS-0201...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GS-0201 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GS-0201 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GS-0201 in Triple-Negative Breast Cancer (TNBC) Drug Details: Small...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brexanolone in Tinnitus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brexanolone in Tinnitus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brexanolone in Tinnitus Drug Details: Brexanolone (Zulresso) is a mixture of allopregnanolone and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Prexasertib Mesylate Monohydrate in Recurrent Medulloblastoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Prexasertib Mesylate Monohydrate in Recurrent Medulloblastoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Prexasertib Mesylate Monohydrate in Recurrent Medulloblastoma Drug Details: Prexasertib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Prexasertib Mesylate Monohydrate in Refractory Medulloblastoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Prexasertib Mesylate Monohydrate in Refractory Medulloblastoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Prexasertib Mesylate Monohydrate in Refractory Medulloblastoma Drug Details: Prexasertib...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Margetuximab in Small-Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Margetuximab in Small-Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Margetuximab in Small-Cell Lung Cancer Drug Details: Margetuximab (Margenza) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Prexasertib Mesylate Monohydrate in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Prexasertib Mesylate Monohydrate in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Prexasertib Mesylate Monohydrate in Endometrial Cancer Drug Details: Prexasertib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Prexasertib Mesylate Monohydrate in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Prexasertib Mesylate Monohydrate in Metastatic Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Prexasertib Mesylate Monohydrate in Metastatic Ovarian Cancer Drug...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CB-103 in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CB-103 in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CB-103 in T-Cell Acute Lymphocytic...